KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Net Margin (2016 - 2025)

Historic Net Margin for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to 103.87%.

  • Bio-Rad Laboratories' Net Margin rose 2111000.0% to 103.87% in Q4 2025 from the same period last year, while for Dec 2025 it was 29.42%, marking a year-over-year increase of 1012700.0%. This contributed to the annual value of 29.42% for FY2025, which is 1012700.0% up from last year.
  • Latest data reveals that Bio-Rad Laboratories reported Net Margin of 103.87% as of Q4 2025, which was up 2111000.0% from 52.36% recorded in Q3 2025.
  • Bio-Rad Laboratories' Net Margin's 5-year high stood at 525.84% during Q3 2021, with a 5-year trough of 480.98% in Q1 2022.
  • For the 5-year period, Bio-Rad Laboratories' Net Margin averaged around 10.75%, with its median value being 13.87% (2023).
  • Per our database at Business Quant, Bio-Rad Laboratories' Net Margin plummeted by -6154600bps in 2022 and then surged by 4911700bps in 2023.
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' Net Margin stood at 213.6% in 2021, then surged by 153bps to 113.35% in 2022, then tumbled by -55bps to 51.34% in 2023, then tumbled by -309bps to 107.24% in 2024, then surged by 197bps to 103.87% in 2025.
  • Its Net Margin was 103.87% in Q4 2025, compared to 52.36% in Q3 2025 and 48.77% in Q2 2025.